Filing Details

Accession Number:
0001209191-14-062654
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-09 16:40:06
Reporting Period:
2014-10-07
Filing Date:
2014-10-09
Accepted Time:
2014-10-09 16:40:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496671 Calithera Biosciences Inc. CALA Pharmaceutical Preparations (2834) 272366329
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1291804 Jean George C/O Advanced Technology Ventures
500 Boylston Street, Suite 1380
Boston MA 02116
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-07 1,810,082 $0.00 1,810,082 No 4 C Indirect By Partnership
Common Stock Acquisiton 2014-10-07 300,000 $10.00 2,110,082 No 4 P Indirect By Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Partnership
No 4 P Indirect By Partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock SERIES A PREFERRED STOCK Acquisiton 2014-10-07 9,166 $0.00 9,166 $0.00
Common Stock SERIES B PREFERRED STOCK Acquisiton 2014-10-07 419,181 $0.00 419,181 $0.00
Common Stock SERIES C PREFERRED STOCK Acquisiton 2014-10-07 747,540 $0.00 747,540 $0.00
Common Stock SERIES D PREFERRED STOCK Acquisiton 2014-10-07 634,195 $0.00 634,195 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a one for one basis immediately prior to the consummation of Issuer's initial public offering of Common Stock and had no expiration date.
  2. ATV Associates VIII, L.L.C. ("ATV A VIII") is the general partner of Advanced Technology Ventures VIII, L.P. ("ATV VIII") and exercises voting and dispositive authority over the shares held by ATV VIII. Jean M. George, a director of the Issuer, is a managing director of ATV A VIII and exercises voting and dispositive decisions of ATV A VIII collectively with each of the four other managing directors. ATV A VIII and each of the managing directors disclaim beneficial ownership of these securities and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein.